As biologics gain greater prominence, protein engineers are adapting to new indications, new advances in targeting science, new product formats, and products that are truly differentiated in the marketplace. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics, including improving product qualities, optimizing lead and candidate selection, and the application of deep sequencing and single cell analysis.
Recombinant Protein Therapeutics
( 重組蛋白質療法 )
Lead and Candidate Selection for Therapeutic Proteins
( 治療用蛋白質的先導化合物和藥劑候補選擇 )
Deep Sequencing and Single Cell Analysis for Antibody Discovery
( 抗體發現的深度定序和單一細胞解析 )